tiprankstipranks
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market
DRREDDY
Dr. Reddy's Laboratories Ltd.
RESEARCH TOOLSreports
Want to see IN:DRREDDY full AI Analyst Report?

Dr. Reddy's Laboratories Ltd. (DRREDDY) Stock Forecast & Price Target

10 Followers
See the Price Targets and Ratings of:

DRREDDY Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Dr.
Reddy's Laboratories Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DRREDDY Stock 12 Month Forecast

There Are No Analyst Ratings for IN:DRREDDY In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

DRREDDY Financial Forecast

DRREDDY Earnings Forecast

Next quarter’s earnings estimate for DRREDDY is ₹9.46 with a range of ₹7.80 to ₹11.25. The previous quarter’s EPS was ₹5.33. DRREDDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.85% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.
Next quarter’s earnings estimate for DRREDDY is ₹9.46 with a range of ₹7.80 to ₹11.25. The previous quarter’s EPS was ₹5.33. DRREDDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.85% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.

DRREDDY Sales Forecast

Next quarter’s sales forecast for DRREDDY is ₹81.46B with a range of ₹72.44B to ₹85.63B. The previous quarter’s sales results were ₹80.70B. DRREDDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.33% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.
Next quarter’s sales forecast for DRREDDY is ₹81.46B with a range of ₹72.44B to ₹85.63B. The previous quarter’s sales results were ₹80.70B. DRREDDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.33% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on IN:DRREDDY
Shyam Srinivasan
Goldman Sachs
Goldman Sachs
₹1,075
Sell
-6.73%
Downside
Downgraded
04/23/26
Dr. Reddy's downgraded to Sell from Neutral at Goldman SachsDr. Reddy's downgraded to Sell from Neutral at Goldman Sachs
Geojit Research Analyst forecast on IN:DRREDDY
Unknown Analyst
Geojit Research
Not Ranked
Geojit Research
₹1,390
Hold
20.60%
Upside
Reiterated
02/23/26
Geojit Research Keeps Their Hold Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Bank of America Securities Analyst forecast on IN:DRREDDY
Neha Manpuria
Bank of America Securities
Bank of America Securities
₹1,600
Buy
38.82%
Upside
Reiterated
12/15/25
Bank of America Securities Keeps Their Buy Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Motilal Oswal Analyst forecast on IN:DRREDDY
Unknown Analyst
Motilal Oswal
Not Ranked
Motilal Oswal
₹1,250
Hold
8.45%
Upside
Reiterated
12/12/25
HSBC Analyst forecast on IN:DRREDDY
Damayanti Kerai
HSBC
HSBC
₹1,400→₹1,450
Buy
25.80%
Upside
Reiterated
10/14/25
HSBC Keeps Their Buy Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Kotak Mahindra Analyst forecast on IN:DRREDDY
Alankar Garude
Kotak Mahindra
Kotak Mahindra
₹1,250
Sell
8.45%
Upside
Reiterated
09/29/25
Kotak Mahindra Keeps Their Sell Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
J.P. Morgan Analyst forecast on IN:DRREDDY
Bansi Desai
J.P. Morgan
J.P. Morgan
₹1,090→₹1,150
Sell
-0.23%
Downside
Reiterated
08/19/25
J.P. Morgan Keeps Their Sell Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on IN:DRREDDY
Shyam Srinivasan
Goldman Sachs
Goldman Sachs
₹1,075
Sell
-6.73%
Downside
Downgraded
04/23/26
Dr. Reddy's downgraded to Sell from Neutral at Goldman SachsDr. Reddy's downgraded to Sell from Neutral at Goldman Sachs
Geojit Research Analyst forecast on IN:DRREDDY
Unknown Analyst
Geojit Research
Not Ranked
Geojit Research
₹1,390
Hold
20.60%
Upside
Reiterated
02/23/26
Geojit Research Keeps Their Hold Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Bank of America Securities Analyst forecast on IN:DRREDDY
Neha Manpuria
Bank of America Securities
Bank of America Securities
₹1,600
Buy
38.82%
Upside
Reiterated
12/15/25
Bank of America Securities Keeps Their Buy Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Motilal Oswal Analyst forecast on IN:DRREDDY
Unknown Analyst
Motilal Oswal
Not Ranked
Motilal Oswal
₹1,250
Hold
8.45%
Upside
Reiterated
12/12/25
HSBC Analyst forecast on IN:DRREDDY
Damayanti Kerai
HSBC
HSBC
₹1,400→₹1,450
Buy
25.80%
Upside
Reiterated
10/14/25
HSBC Keeps Their Buy Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Kotak Mahindra Analyst forecast on IN:DRREDDY
Alankar Garude
Kotak Mahindra
Kotak Mahindra
₹1,250
Sell
8.45%
Upside
Reiterated
09/29/25
Kotak Mahindra Keeps Their Sell Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
J.P. Morgan Analyst forecast on IN:DRREDDY
Bansi Desai
J.P. Morgan
J.P. Morgan
₹1,090→₹1,150
Sell
-0.23%
Downside
Reiterated
08/19/25
J.P. Morgan Keeps Their Sell Rating on Dr. Reddy's Laboratories Ltd. (DRREDDY)
Stocks with the Highest Top Analyst Consensus in the General Sector
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
CBRSCerebras Systems, Inc. Class A
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Reddy's Laboratories Ltd.

3 Months
Damayanti KeraiHSBC
Success Rate
1/3 ratings generated profit
33%
Average Return
-1.30%
Copying Damayanti Kerai's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -1.30% per trade.
1 Year
Bansi DesaiJ.P. Morgan
Success Rate
2/4 ratings generated profit
50%
Average Return
+1.07%
Copying Bansi Desai's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +1.07% per trade.
2 Years
Bansi DesaiJ.P. Morgan
Success Rate
4/4 ratings generated profit
100%
Average Return
+5.35%
Copying Bansi Desai's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DRREDDY Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
0
0
0
0
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
2
1
1
0
0
In the current month, DRREDDY has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DRREDDY average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

DRREDDY Stock Forecast FAQ

What is IN:DRREDDY’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:DRREDDY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:DRREDDY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Dr. Reddy's Laboratories Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Dr. Reddy's Laboratories Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Dr. Reddy's Laboratories Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Dr. Reddy's Laboratories Ltd.?
      To buy shares of IN:DRREDDY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.